This topic contains a solution. Click here to go to the answer

Author Question: Prior to initiating medication therapy with phenelzine (Nardil), the nurse should plan to deter-mine ... (Read 69 times)

TVarnum

  • Hero Member
  • *****
  • Posts: 548
Prior to initiating medication therapy with phenelzine (Nardil), the nurse should plan to deter-mine the client's:
 
  1. Mood and affect
  2. Activity level
  3. Cognitive ability to understand information about the medication
  4. Support network and its members' willingness to participate in treatment

Question 2

A client who has a history of bipolar disorder recently underwent orthopedic surgery and was discharged to return home.
 
  When visited by the home care nurse, the nurse documented the following: slow and soft speech; sad facial expression; client crying when describing extreme fatigue, low mood, and the feeling that he will never get well. He has refused to bathe and perform ADLs for several days. Which nursing diagnosis would be appropriate?
  1. Disturbed thought processes related to bipolar disorder
  2. Deficient knowledge related to depression and surgery
  3. Self-care deficit related to orthopedic surgery and possible depression
  4. Situational low self-esteem related to immobility



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANS: 3
Phenelzine (Nardil) administration requires strict adherence to a restricted diet. The client must have the cognitive ability to understand the food and medication interactions that may cause a serious reaction.

Answer to Question 2

ANS: 3
Refusal to perform tasks of bathing, grooming, and other ADLs provides evidence of a self-care deficit. The other symptoms documented by the nurse are characteristic of depression. Thus op-tion 3 is a viable nursing diagnosis. No data are present to suggest the diagnoses given in the other options.





 

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library